Multi-organ model assessment of neurotoxicity following exposure of liver spheroids to drugs
Open Access
- 4 April 2025
- journal article
- Published by Elsevier in Biomedicine & Pharmacotherapy
- Vol. 186, 118021
Abstract
No abstract availableKeywords
Funding Information
- Boston Area Diabetes Endocrinology Research Center (DK135043)
- Harvard University
- National Institutes of Health (S10 OD032211-01)
This publication has 67 references indexed in Scilit:
- The FDA Modernization Act 2.0: Drug Testing in Animals is Rendered OptionalThe American Journal of Medicine, 2023
- Organs-on-a-chip models for biological researchCell, 2021
- Advances in development and application of human organoids3 Biotech, 2021
- Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injuryArchives of Toxicology, 2017
- Arsenic, Cadmium, and Lead Like Troglitazone Trigger PPARγ-Dependent Poly (ADP-Ribose) Polymerase Expression and Subsequent Apoptosis in Rat Brain AstrocytesMolecular Neurobiology, 2017
- Mechanistic evaluation of primary human hepatocyte culture using global proteomic analysis reveals a selective dedifferentiation profileArchives of Toxicology, 2016
- Multi-cell type human liver microtissues for hepatotoxicity testingArchives of Toxicology, 2012
- Responses induced by tacrine in neuronal and non-neuronal cell linesJournal of Neuroscience Research, 1998
- Nefazodone pharmacokinetics: assessment of nonlinearity, intra-subject variability and time to attain steady-state plasma concentrations after dose escalation and de-escalationEuropean Journal of Clinical Pharmacology, 1996
- Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans*Clinical Pharmacology & Therapeutics, 1995